Table 3.

Factors associated with nutrition programme failure among HIV-infected adults treated in Kenya and Uganda, 2006-2008

Factors	Adjusted (Model 1)		Adjusted (Model 2)
	OR (95% CI)	P value	OR (95% CI)	P value
Treatment cohort
Arua	1.0	0.01	1.0	0.007
Homa Bay	1.5 (1.0-2.3)		1.7 (1.1-2.4)
Mathare	0.7 (0.4-1.0)		0.8 (0.5-1.1)
Period of admission in the NP
Years 2005 - 2006	1.0	0.1	1.0	0.1
January-June 2007	0.8 (0.5-1.2)		0.8 (0.6-1.2)
July 2007-June 2008	1.1 (0.8-1.6)		1.1 (0.8-1.2)
In the HIV programme
Patients already in care	1.0	0.5	1.0	0.5
New patients	1.1 (0.8-1.6)		1.1 (0.8-1.6)
Age at NP admission, years
≥45	1.0	0.2	1.0	0.4
30-44	1.0 (0.6-1.5)		1.0 (0.6-1.4)
15-29	0.7 (0.4-1.2)		0.8 (0.5-1.2)
Gender
Women	1.0	0.001	1.0	0.001
Men	1.6 (1.2-2.1)		1.5 (1.2-2.0)
Malnutrition at admission
Moderate	1.0	<0.0001	1.0	<0.0001
Severe	2.2 (1.7-3.0)		2.2 (1.7-2.8)
Recorded clinical diagnoses
TB at NP admission	0.9 (0.6-1.3)	0.7	0.9 (0.6-1.3)	0.6
TB diagnosed during NP follow up	1.0 (0.7-1.4)	0.9	1.0 (0.7-1.4)	0.9
Extensive candidiasis at NP admission	1.4 (0.6-3.4)	0.4	1.2 (0.5-2.6)	0.7
Diarrhoea at NP admission	1.3 (0.8-2.0)	0.3	1.3 (0.8-2.0)	0.3
ART status at admission
On ART	1.0	<0.0001	1.0	<0.0001
Eligible but never started on ART	6.2 (3.5-11.1)		4.5 (2.7-7.7)
Eligible & ART initiated at or after NP admission	0.5 (0.3-0.8)		0.6 (0.4-0.9)
Ineligible for ART	1.4 (0.9-2.3)		1.6 (1.0-2.5)

Model 1: Results from analysis where deaths, lost to follow up and uncured were classified as NP failure; and patients with NP outcome defined as "other" were excluded from the model.

Model 2: Results from analysis where deaths, lost to follow up, uncured, patients with intolerance to RUTF and those who stopped nutritional therapy for other reasons were classified as "programme failure".

ART - antiretroviral therapy; NP - nutrition programme; OR - odds ratio; TB - tuberculosis